North America Cardiac Monitoring Market at a CAGR of 1.5%; Dominated by Top Competitors (ABBOTT, APPLIED CARDIAC SYSTEMS, BOSTON SCIENTIFIC, CARDIAC SCIENCE CORPORATION, GE HEALTHCARE, LIFEWATCH AG, MEDTRONIC, MENNEN MEDICAL)

The North America cardiac monitoring market is expected to register a CAGR of about 1.5% during 2018-2023 (the forecast period). A cardiac monitoring device monitors and can diagnose various abnormalities or disorders of the human heart, along with the overall cardiovascular system.

Detailed Sample Copy of Updated Analysis @ https://www.marketprognosis.com/sample-request/16944
Note: “If this link doesn’t work in Internet Explorer, kindly try copy pasting it in other browsers”.

The US to Lead the Market in North America
In 2017, the US cardiac monitoring market holds the largest market share in North America, due to the large patient pool and wide acceptance for advanced technologies.

Key Developments in the Market
• Sep 2017: ABBOTT Confirm Rxu2122 Insertable Cardiac Monitor (ICM) became world's first and only smartphone compatible ICM, which received a clearance from FDA.
• July 2017: GE Healthcare collaborated with Heartflow.

Major Players:
ABBOTT, APPLIED CARDIAC SYSTEMS, BOSTON SCIENTIFIC, CARDIAC SCIENCE CORPORATION, GE HEALTHCARE, LIFEWATCH AG, MEDTRONIC, MENNEN MEDICAL, PHILLIPS HEALTHCARE, SCHILLER AMERICAS INC., SIEMENS HEALTHCARE, TOSHIBA MEDICAL SYSTEMS, among others.

Get Quality Discount @ https://www.marketprognosis.com/discount-request/16944
Note: “If this link doesn’t work in Internet Explorer, kindly try copy pasting it in other browsers”.

Rise in the Incidences of Cardiovascular Diseases
According to the American Heart Association (AHA), the cardiovascular diseases account for nearly 17.3 million deaths per year. The Centre for Disease Control and Prevention states that, about 610,000 people die of heart diseases in the United States every year, i.e. one in every four deaths. Coronary heart disease (CHD) is the most common type of heart disease, with a death toll of over 370,000 people, annually. The rate of diagnosis for cardiovascular diseases is increasing over time, due to high incidence and prevalence rates of cardiac diseases, controlling mortality rates by early diagnosis and treatment for CVD, with the help of cardiac monitoring devices. This, in turn, is driving the overall market growth. The other factors, such as investments in R&D activities of heart disease detection, ease and use of portability in devices, and the demand for home-based, point-of-care, and remote monitoring cardiac systems are the major drivers for the market growth.

Risk of Infection Due to Implantable Monitoring Devices
A cardiac monitoring device is used for patients who require constant heart monitoring. Monitoring the cardiac output is a common practice for the patients who undergo surgeries that use anesthesia and require critical care. Cardiac implantable devices are used for related cardiac surgeries to monitor heart rates, continuously. Patients, who undergo any invasive procedures, are at a risk of infections. Moreover, cardiac patients are more prone to infections than others. The increasing rate of infections, due to these devices, has tremendous economic implications on hospitals. Patients who are implanted with these monitoring devices are likely to require prolonged hospital stays, where the related costs can rack up quickly. However, minimally-invasive cardiac output monitors, for clinical practices, have been introduced in the market, which do not require the insertion of a Pacemaker. These devices utilize different techniques to monitor, and each has its own source of potential set of errors and degree of invasiveness. Hence, the risk of infection, due to implantable medical devices, is a constraint for the market growth. The other major restraint for the North America Cardiac Monitoring Market is the low level of accuracy with invasive cardiac output monitoring devices.

Browse Report @ https://www.marketprognosis.com/enquiry/16944
Note: “If this link doesn’t work in Internet Explorer, kindly try copy pasting it in other browsers”.

About Market Prognosis
We at Market Prognosis believe in giving a crystal clear view of market dynamics for achieving success in today’s complex and competitive marketplace through our quantitative & qualitative research methods.
We help our clients identify the best market insights and analysis required for their business thus enabling them to take strategic and intelligent decision.
We believe in delivering actionable insights for your business growth and success.

Contact us:
ProgMarkPvt Ltd,
Thane - 421501
India.
Contact No: +1 973 241 5193
Email: sales@marketprognosis.com

This release was published on openPR.